Abstract
In 110 patients with essential arterial hypertension (EAH) and overweight or abdominal obesity (AO) analyzed changes of peripheral hemodynamics and clinical signs under the influence of treatment, depending on genes’ polymorphism of the Angiotensin-converting enzyme (ACE, I/D) and the Peroxisome proliferator-activated receptor gamma-2 (PPAR-2, Pro12Ala). Under the combined treatment the target office blood pressure (BP) was achieved in 72.8 % subjects, the adequate reduction of BP – in 82.6 % patients. Depending on the EAH severity: target BP achieved in 100% patients with EAH I stage vs 76.2 % in person with EAH II stage (p=0.019) and 53.1 % – with EAH III stage (p=0.002). Target average daily BP24, daily BPd and nighttime BPn were achieved in 70.0 % patients (prevail those with EAH I-II stages by 47.1 % and 21.2 % (p=0.049), respectively, in I-allele carriers of ACE gene – by 17,9% (p=0.048) and Ala-allele carriers of PPAR-2 gene by 38.9 % (p=0.036).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
